Tracheobronchopexy to Avoid Tracheostomy in Esophageal Atresia Patients With Severe Life-Threatening Tracheobronchomalacia
Topic overview
Study of 80 esophageal atresia patients demonstrates that tracheobronchopexy effectively treats severe life-threatening tracheobronchomalacia, eliminating blue spells/BRUEs and enabling 94% to avoid tracheostomy. Median 39-month follow-up shows sustained reduction in ventilator dependence with 5% mortality related primarily to comorbidities.
Key takeaways
- Tracheobronchopexy successfully eliminated blue spells/BRUEs in EA patients with severe TBM and avoided tracheostomy in 94% of cases.
- Most EA patients (90%) had complete airway collapse on preoperative bronchoscopy, requiring surgical intervention at median age 6 months.
- Posterior approach tracheobronchopexy was most common (73%), with thoracic trachea alone addressed in 58% of cases.
- Significant reduction in positive pressure ventilation and ventilator dependence post-operatively (p<0.001) at median 39-month follow-up.
- Low mortality (5%) with one 30-day operative death; tracheobronchopexy should be first-line treatment for severe life-threatening TBM in EA.
Comments